![]()
![]()
![]()
Fig. 1. Generation of Mi3-EDIII nanoparticle vaccine.
![]()
Fig. 2. Antigenic profiling of Mi3-EDIII.
![]()
Fig. 3. Immunogenicity of Mi3-EDIII in C57BL/6 mice.
![]()
Fig. 4. Protective efficacy of Mi3-EDIII in challenged neonatal mice.
![]()
Fig. 5. Immunogenicity and protective efficacy of Mi3-EDIII in Ifnar1 C57BL/6 mice.
![]()
Fig. 6. ADE effects of immune sera on ZIKV or DENV infection in K562 cells.
![]()
Supplementary Fig. S1. Neutralizing activities of mAbs 7B3, 8D10 and 8-4.
![]()
Supplementary Fig. S2. SDS-PAGE analysis of recombinant E404.
![]()
Supplementary Fig. S3. Frequency of GC B cells among total B cells in ILNs at week 8.
欢迎来到医食参考新媒体矩阵
2023年疫苗接种攻略
阳过了,该怎么打疫苗?最全接种指导手册来了
撰写| 中国病毒学英文版
校稿| Gddra编审| Hide / Blue sea
编辑 设计| Alice
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.